RecruitingNCT04226898
Study of a synbiotic supplement in schizophrenia
About this title
Read the official source — NCT04226898Placebo comparisonAges 18–65United States
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- BatlimoreSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 21, 2022
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 68
- Sponsor
- Sheppard Pratt Health System
- Sponsor type
- Unknown or unclear
- Study type
- Biological
- Intervention type
- Biological
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT04226898
- Official title
Show the full official title
A Double-Blind Placebo-Controlled Trial of the Synbiotic Compound Probio-Tec ABCG for Schizophrenia Patients With and Without Elevated Markers of Gastrointestinal Inflammation
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Batlimore
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Sheppard Pratt Health System.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
